Fig. 2.
CLL-specific immune responses in cohort I, II, and III. a IFN-γ ELISPOT and b lymphocyte proliferation assay in the individual patients comparing pre-vaccination and follow-up. * indicates leukemia-specific immune response; (+) indicates response meeting the criteria for a vaccine-induced immune response (see “Patients and methods” for definition). SFC spot-forming cells, CPM count per minute